These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8290015)

  • 1. Effect of human recombinant erythropoietin treatment on erythrocyte delta-aminolevulinic acid dehydratase in patients on maintenance hemodialysis.
    Djordjević VB; Pavlović D; Pejović M; Lecić N; Koraćević D; Djordjević V; Stefanović V
    Nephron; 1993; 65(3):497-8. PubMed ID: 8290015
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on hemodialysis.
    Fontanellas A; Herrero JA; Coronel F; Santos JL; Morán MJ; Barrientos A; Enríquez de Salamanca R
    J Am Soc Nephrol; 1996 May; 7(5):774-9. PubMed ID: 8738813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Delta aminolevulinic acid dehydratase activity in red cells and delta aminolevulinic acid urinary excretion in puerperants with anemia].
    Tomaszewski J; Kreczko S; Bielecki M
    Ginekol Pol; 1978 Oct; 49(10):893-7. PubMed ID: 720905
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythrocyte delta-aminolaevulinic acid dehydratase activity and changes in delta-aminolaevulinic acid concentration in various forms of anaemia.
    Campbell BC; Meredith PA; Moore MR; Goldberg A
    Br J Haematol; 1978 Nov; 40(3):397-400. PubMed ID: 749926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered 5-aminolevulinic acid metabolism leading to pseudoporphyria in hemodialysed patients.
    Guolo M; Stella AM; Melito V; Parera V; Del C Batlle AM
    Int J Biochem Cell Biol; 1996 Mar; 28(3):311-7. PubMed ID: 8920640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin and haemodialyser re-use.
    Dos Santos JP; Prata MM; Sousa FT; Barbas JV
    Nephron; 1990; 56(4):447-8. PubMed ID: 2080010
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis.
    Salvati F; Strippoli P; Barchetti M; Scatizzi A
    Nephron; 1992; 60(3):371. PubMed ID: 1373475
    [No Abstract]   [Full Text] [Related]  

  • 11. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients].
    Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T
    Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility of living organism to lead poisoning. Part 1. The normal value of erythrocyte delta-aminolevulinic acid dehydratase activity in rats and humans (author's transl)].
    Maruta H
    Sangyo Igaku; 1977 Mar; 19(2):67-74. PubMed ID: 916329
    [No Abstract]   [Full Text] [Related]  

  • 13. Reticulocyte count used to assess recombinant human erythropoietin sensitivity in hemodialysis patients.
    Tatsumi N; Kojima K; Tsuda I; Yamagami S; Itoh Y; Tanaka H
    Contrib Nephrol; 1990; 82():41-8. PubMed ID: 2093525
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin.
    Haberl M
    Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis.
    Sayinalp N; Erdem Y; Haznedaroğlu IC; Dündar S; Cağlar S; Kirazli S
    Clin Nephrol; 1995 Dec; 44(6):404. PubMed ID: 8719556
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythropoietin, aluminum and renal anemia].
    Schaefer M; Heidland A
    Dtsch Med Wochenschr; 1990 Jun; 115(22):878-9. PubMed ID: 2347300
    [No Abstract]   [Full Text] [Related]  

  • 18. Heme synthesis in anemia of the uremic state.
    Linkesch W; Stummvoll HK; Wolf A; Müller M
    Isr J Med Sci; 1978 Nov; 14(11):1173-6. PubMed ID: 750546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group.
    Laupacis A
    Transplant Proc; 1991 Apr; 23(2):1825-6. PubMed ID: 2053167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythrocyte delta-aminolevulinic acid dehydratase activity in patients with polychlorobiphenyl poisoning].
    Lu FJ; Wang SH; Wu YC; Lin RY
    Taiwan Yi Xue Hui Za Zhi; 1984 Jan; 83(1):27-33. PubMed ID: 6427393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.